Welltica+ on MSN: New treatment may nearly double effectiveness against aggressive breast cancer
A particular type of breast cancer has long been difficult to treat. New research now suggests that a novel method could change the situation for some patients.
Add Yahoo as a preferred source to see more of our stories on Google. Since the first Breast Cancer Awareness Month initiatives kicked off 40 years ago, major improvements have been made in treating ...
Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes ...
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to ...
MSN: A New Treatment Combination Shows Promise For Hard-To-Treat Triple-Negative Breast Cancer — What New Data Means For Patients
The targeted drug called sacituzumab govitecan-hziy (brand name: Trodelvy) is showing promise for patients with a difficult-to-treat type of breast cancer known as triple-negative breast cancer when ...
A New Treatment Combination Shows Promise For Hard-To-Treat Triple-Negative Breast Cancer — What New Data Means For Patients
News Medical: New antibody drug conjugates can transform early HER2-positive breast cancer treatment
ascopubs.org: Breast Cancer in Cape Verde: Clinical-Molecular Profile and Impact of an International Treatment Partnership
Breast Cancer in Cape Verde: Clinical-Molecular Profile and Impact of an International Treatment Partnership
Live 5 News: Upcoming MUSC clinical trial helping to find another way to treat breast cancer
MOUNT PLEASANT, S.C. (WCSC) - A new study at the Medical University of South Carolina is hoping to find new treatment options for women dealing with an aggressive form of breast cancer and heart ...